Life sciences companies increasingly turning to arbitration
The following Arbitration news provides comprehensive and up to date legal information on Life sciences companies increasingly turning to arbitration
Lexis®PSL Life Sciences is an online practical guidance product for contentious and non-contentious lawyers providing advice to and supporting the UK’s Life Sciences sector.
Our content is written and structured to cover each stage in the life-cycle of a Life Sciences product from research and development to manufacturing, marketing and sale, including analyses of sector specific IP and data protection issues.
Our practice notes set out key principles supported by relevant authority and links through to in-depth commentary and underlying sources in Lexis®Library, all of which are designed to speed up the task of advising in this fast-moving and innovative sector.
LexisPSL Life Sciences is supported by an in-house legal team with extensive experience in practice and dedicated to producing content specifically for busy practitioners. This experience, combined with extensive customer research, has shaped our practical guidance on issues affecting the UK’s Life Sciences sector. We have built and continue to develop our product with the assistance of leading experts in the field.